Generex Biotechnology (QB) News - GNBT

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Generex Biotechnology Corporation (QB) GNBT OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.0999 -19.98% 0.4001 0.40 0.5299 0.486 0.50 16:36:15
more quote information »

Recent News

Date Time Source Heading
3/20/202013:55EDGARQuarterly Report (10-q)
3/17/202011:45EDGARCurrent Report Filing (8-k)
3/16/202016:31EDGARNotification That Quarterly Report Will Be Submitted Late..
3/13/202009:20EDGARCurrent Report Filing (8-k)
3/02/202014:44EDGARCurrent Report Filing (8-k)
2/18/202014:13EDGARSecurities Registration Statement (s-1)
2/13/202014:05EDGARAmended Statement of Ownership (sc 13g/a)
1/28/202016:49EDGARCurrent Report Filing (8-k)
1/07/202011:58EDGARCurrent Report Filing (8-k)
12/16/201917:25EDGARQuarterly Report (10-q)
12/12/201912:46EDGARSecurities Registration Statement (s-1)
11/29/201913:34EDGARStatement of Ownership (sc 13g)
11/27/201910:06EDGARCurrent Report Filing (8-k)
11/25/201911:45IHNWGNBT - Generex Biotechnology Signs Stock Purchase Agreement..
11/12/201909:31EDGARAnnual Report (10-k)
11/05/201910:38IHNWGNBT Announces First-in-Human Clinical Trial of ALTuCELL..
10/31/201910:51IHNWGNBT - BioPharma w/10x Potential - Cancer and Diabetes..
10/29/201915:11EDGARAmended Current Report Filing (8-k/a)
10/29/201913:55EDGARCurrent Report Filing (8-k)
10/29/201913:20EDGARCurrent Report Filing (8-k)
10/29/201913:14EDGARNotification That Annual Report Will Be Submitted Late (nt..
10/29/201913:11EDGARCurrent Report Filing (8-k)
10/23/201914:32IHNWWHY GNBT COULD MOVE BIG SOON
10/01/201912:37IHNWGenerex Biotechnology Subsidiary Olaregen Therapeutix..
9/24/201916:34EDGARProxy Statement (definitive) (def 14a)
9/18/201909:26IHNWGNBT - GENEREX BIOTECHNOLOGY ASSEMBLING MASSIVE GROWTH..
9/17/201909:29IHNWGNBT Announces 1st Phase II Clinical Trial Patient for..
9/12/201913:29IHNWGNBT Announces On-Demand Corprate Webcast From 21st Annual..
9/11/201915:46EDGARInitial Statement of Beneficial Ownership (3)
9/10/201911:34IHNWGNBT - Generex Signs LOI to Establish NuGenerex Health MSO..
9/09/201911:42IHNWGNBT Signs LOI to Acquire Altsulin® with Patented..
8/19/201909:09IHNWGNBT Acquires Additional 38% of Subsidiary Olararegen..
8/09/201910:51IHNWGNBT - Buy One Share Of Biotech's New Fast Rising Star And..
7/26/201910:35IHNWGNBT - Generex Biotechnology Provides a Summary of Its..
7/16/201916:00EDGARCurrent Report Filing (8-k)
7/15/201914:24IHNWGNBT - Biotech's New Rising Star
7/10/201908:44IHNWGNBT - Generex Biotechnology Provides Fiscal Year Overview
6/26/201914:48IHNWGNBT - Generex Biotechnology Subsidiary Olaregen Therapeutix..
6/20/201910:42IHNWGNBT - Generex Declares 1 for 1 Stock Dividend In..
6/19/201917:21EDGARQuarterly Report (10-q)
6/17/201910:31EDGARNotification That Quarterly Report Will Be Submitted Late..
6/12/201913:02IHNWGDET and KALY Rated BULLISH and GNBT Gets BUY Recommendation..
6/07/201910:32IHNWGNBT- Generex Provides Update to Pending 1:1 Stock Dividend
6/05/201917:12EDGARAmended Current Report Filing (8-k/a)
6/05/201916:34EDGARCurrent Report Filing (8-k)
5/16/201913:08IHNWZevotek, Inc. (USOTC: ZVTK) Rated Overall Bullish On $85..
5/14/201914:06EDGARInitial Statement of Beneficial Ownership (3)
4/29/201909:00IHNWGNBT - Generex Biotechnology Announces Organizational..
4/24/201907:00IHNWHealthcare Technology Seeks to Address Aging Population..
4/18/201913:16NMWGNBT Subsidiary Olaregen Therapeutix Sponsors Prestigious..
See more news about this stock »
Your Recent History
USOTC
GNBT
Generex Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200404 18:24:31